200 related articles for article (PubMed ID: 29779047)
21. Recent Advances in Histopathological and Molecular Diagnosis in Pheochromocytoma and Paraganglioma: Challenges for Predicting Metastasis in Individual Patients.
Yamazaki Y; Gao X; Pecori A; Nakamura Y; Tezuka Y; Omata K; Ono Y; Morimoto R; Satoh F; Sasano H
Front Endocrinol (Lausanne); 2020; 11():587769. PubMed ID: 33193100
[TBL] [Abstract][Full Text] [Related]
22. Paraganglioma: not just an extra-adrenal pheochromocytoma.
Laird AM; Gauger PG; Doherty GM; Miller BS
Langenbecks Arch Surg; 2012 Feb; 397(2):247-53. PubMed ID: 22086065
[TBL] [Abstract][Full Text] [Related]
23. Pheochromocytoma in MEN 2A syndrome. Study of 54 patients.
Rodriguez JM; Balsalobre M; Ponce JL; Ríos A; Torregrosa NM; Tebar J; Parrilla P
World J Surg; 2008 Nov; 32(11):2520-6. PubMed ID: 18795243
[TBL] [Abstract][Full Text] [Related]
24. Pheochromocytoma: A three-decade clinical experience in a multicenter study.
Iglesias P; Santacruz E; García-Sancho P; Marengo AP; Guerrero-Pérez F; Pian H; Fajardo C; Villabona C; Díez JJ
Rev Clin Esp (Barc); 2021 Jan; 221(1):18-25. PubMed ID: 33998473
[TBL] [Abstract][Full Text] [Related]
25. Adrenomedullary hyperplasia and phaeochromocytoma. DNA cytophotometric findings in 47 cases.
Padberg BC; Garbe E; Achilles E; Dralle H; Bressel M; Schröder S
Virchows Arch A Pathol Anat Histopathol; 1990; 416(5):443-6. PubMed ID: 2107632
[TBL] [Abstract][Full Text] [Related]
26. Locally invasive recurrence or metastasis of pheochromocytoma into the liver?-clinicopathological challenges.
Tang SS; Lee JWK; Wijerethne S; Iyer SG; Hue S; En NM; Parameswaran R
World J Surg Oncol; 2022 Nov; 20(1):360. PubMed ID: 36368995
[TBL] [Abstract][Full Text] [Related]
27. Size of the tumor and pheochromocytoma of the adrenal gland scaled score (PASS): can they predict malignancy?
Agarwal A; Mehrotra PK; Jain M; Gupta SK; Mishra A; Chand G; Agarwal G; Verma AK; Mishra SK; Singh U
World J Surg; 2010 Dec; 34(12):3022-8. PubMed ID: 20703467
[TBL] [Abstract][Full Text] [Related]
28. Intra-tumoral molecular heterogeneity in benign and malignant pheochromocytomas and extra-adrenal sympathetic paragangliomas.
Korpershoek E; Stobbe CK; van Nederveen FH; de Krijger RR; Dinjens WN
Endocr Relat Cancer; 2010 Sep; 17(3):653-62. PubMed ID: 20488782
[TBL] [Abstract][Full Text] [Related]
29. Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.
Korpershoek E; Petri BJ; van Nederveen FH; Dinjens WN; Verhofstad AA; de Herder WW; Schmid S; Perren A; Komminoth P; de Krijger RR
Endocr Relat Cancer; 2007 Jun; 14(2):453-62. PubMed ID: 17639058
[TBL] [Abstract][Full Text] [Related]
30. [Pheochromocytoma associated with multiple endocrine neoplasia 2A and sporadic: differential characteristics].
Lecube A; Hernández C; Oriola J; Tovar JL; Gémar E; Baena JA; Mesa J; Simó R
Med Clin (Barc); 2000 Oct; 115(11):405-9. PubMed ID: 11093842
[TBL] [Abstract][Full Text] [Related]
31. Nationwide French Study of RET Variants Detected from 2003 to 2013 Suggests a Possible Influence of Polymorphisms as Modifiers.
Lebeault M; Pinson S; Guillaud-Bataille M; Gimenez-Roqueplo AP; Carrie A; Barbu V; Pigny P; Bezieau S; Rey JM; Delvincourt C; Giraud S; Veyrat-Durebex C; Saulnier P; Bouzamondo N; Chabbert M; Blin J; Mohamed A; Romanet P; Borson-Chazot F; Rohmer V; Barlier A; Mirebeau-Prunier D
Thyroid; 2017 Dec; 27(12):1511-1522. PubMed ID: 28946813
[TBL] [Abstract][Full Text] [Related]
32. [A comparison of clinical characteristics between 2 pedigrees of multiple endocrine neoplasia type 2A with different RET mutations].
Weng Y; Xue SN; Zhang SL; Cheng H; Yan L
Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):134-137. PubMed ID: 29397600
[TBL] [Abstract][Full Text] [Related]
33. [112 cases of sporadic and genetically determined pheochromocytoma: a comparative pathologic study].
Gosset P; Lecomte-Houcke M; Duhamel A; Labat-Moleur F; Patey M; Floquet J; Viennet G; Berger-Dutrieux N; Caillou B; Franc B
Ann Pathol; 1999 Dec; 19(6):480-6. PubMed ID: 10617804
[TBL] [Abstract][Full Text] [Related]
34. Topographic molecular profile of pheochromocytomas: role of somatic down-regulation of mismatch repair.
Blanes A; Sanchez-Carrillo JJ; Diaz-Cano SJ
J Clin Endocrinol Metab; 2006 Mar; 91(3):1150-8. PubMed ID: 16394087
[TBL] [Abstract][Full Text] [Related]
35. [Pheochromocytomas in adrenal medulla or extra-adrenal and multiple endocrine neoplasms:a clinicopathologic analysis of 181 cases].
Jiang CX; Zeng Z; Wang T; Liu X; Liu R; Li Y
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):762-6. PubMed ID: 22336161
[TBL] [Abstract][Full Text] [Related]
36. Coexistence of MEN 2A and papillary thyroid carcinoma and a recurrent pheochromocytoma 23 years after surgery: report of a case and a review of the Japanese literature.
Oishi S; Sasaki M; Sato T; Isogai M
Jpn J Clin Oncol; 1995 Aug; 25(4):153-8. PubMed ID: 7666591
[TBL] [Abstract][Full Text] [Related]
37. A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A.
Martins AF; Martins JM; do Vale S; Dias T; Silveira C; da Silva IR; Carmo-Fonseca M
Hormones (Athens); 2016 Jul; 15(3):435-440. PubMed ID: 27838608
[TBL] [Abstract][Full Text] [Related]
38. Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma.
Koch CA; Huang SC; Zhuang Z; Stolle C; Azumi N; Chrousos GP; Vortmeyer AO; Pacak K
Oncogene; 2002 Jan; 21(3):479-82. PubMed ID: 11821960
[TBL] [Abstract][Full Text] [Related]
39. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
[TBL] [Abstract][Full Text] [Related]
40. Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas.
Kim KY; Kim JH; Hong AR; Seong MW; Lee KE; Kim SJ; Kim SW; Shin CS; Kim SY
PLoS One; 2016; 11(12):e0168413. PubMed ID: 27992508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
